Why Fulcrum Therapeutics Shares Are Trading Lower By Over 55%? Here Are Other Stocks Moving In Friday's Mid-Day Session
$AKBA
$AMAM
$ASLN
$BAER
Biotechnology: Pharmaceutical Preparations
Health Care
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Gainers
- Bridger Aerospace Group Holdings, Inc. (NASDAQ:BAER) shares jumped 129.6% to $10.15. Jeffrey E. Kelter reported a 22.4% stake in a 13D filing on Thursday.
- Cingulate Inc (NASDAQ:CING) rose 66% to $1.8106 after the company reported top-line results from the fed/fast study of CTx-1301-003 for ADHD. The trial demonstrated that CTx-1301 can be taken with or without food.
- Intuitive Machines, Inc. (NASDAQ:LUNR) jumped 48% to $30.19.
- Timber Pharmaceuticals, Inc. (NASDAQ:TMBR) gained 39.3% to $2.69 after the company announced the European Commission granted orphan drug designation for TMB-001 for the treatment of X-linked recessive ichthyosis.
- Beyond Meat, Inc. (NASDAQ:BYND) gained 21.9% to $20.90 after the company reported better-than-expected Q4 results.
- AVITA Medical, Inc. (NASDAQ:RCEL) rose 21.1% to $10.97 following strong quarterly results.
- ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) jumped 18.6% to $0.8298. The company announced completion of recruitment in the Phase 2b TREK-AD study and also announced a $20 million private placement.
- Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) gained 18.4% to $13.58 after the company posted strong quarterly sales.
- Navitas Semiconductor Corporation (NASDAQ:NVTS) rose 18% to $6.81 following strong quarterly results.
- Zeta Global Holdings Corp. (NYSE:ZETA) jumped 15.3% to $10.45 following quarterly results.
- MediaAlpha, Inc. (NYSE:MAX) gained 13% to $16.39 after the company reported Q4 financial results.
- Akebia Therapeutics Inc (NASDAQ:AKBA) rose 12.7% to $0.8340. Akebia received CHMP opinion in Europe for vafseo for treatment of symptomatic anaemia associated with chronic kidney disease in adults on chronic maintenance dialysis.
- Paymentus Holdings, Inc. (NYSE:PAY) gained 12.5% to $9.07 following Q4 results.
- Celularity Inc. (NASDAQ:CELU) gained 10% to $0.6524.
- Lucira Health Inc (NASDAQ:LHDX) shares rose 9.5% to $0.1351. Lucira Health shares dropped over 45% on Thursday after the company announced it will pursue a strategic sale of its business through the voluntary Chapter 11 process.
- Beacon Roofing Supply, Inc. (NASDAQ:BECN) gained 8.8% to $64.96 following Q4 results.
- Farfetch Ltd (NYSE:FTCH) rose 7.2% to $5.30 after the company reported better-than-expected Q4 results. The company also said that its CFO will step down by end of 2023.
Losers
- Fulcrum Therapeutics, Inc. (NASDAQ:FULC) shares dipped 55.7% to $5.70 after the company announced a clinical hold on FTX-6058 in sickle cell disease.
- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) fell 55% to $1.65 after the company announced pricing of a $20 million underwritten public offering.
- Nektar Therapeutics (NASDAQ:NKTR) fell 45% to $1.60 after the company reported its SLE trial failed to achieve its primary endpoint.
- Obseva SA (NASDAQ:OBSV) dipped 38% to $0.10 after the company announced strategic reorganization to consolidate operations in Switzerland.
- CS Disco Inc (NYSE:LAW) dropped 37.7% to $5.85 following quarterly results.
- Open Lending Corp (NASDAQ:LPRO) dropped 35.5% to $5.58 following weak quarterly results.
- Infobird Co Ltd (NASDAQ:IFBD) fell 34.8% to $0.95 after the company announced pricing of a $5 million registered direct offering.
- Upland Software Inc (NASDAQ:UPLD) dropped 34% to $5.76 after the company reported mixed Q4 financial results. Following earnings, Needham downgraded the stock from Buy to Hold.
- Inogen Inc (NASDAQ:INGN) fell 31.4% to $15.88 following weak quarterly sales.
- Vicor Corp (NASDAQ:VICR) dropped 27.2% to $41.01 after the company reported mixed Q4 financial results.
- Sono Group NV (NASDAQ:SEV) fell 26.8% to $0.61 after the company announced it will focus exclusively on its solar tech company and has terminated the Sion program. The company also said it plans the redundancy of roughly 300 employees, in light of the decision to terminate the Sion program.
- Bigcommerce Holdings Inc (NASDAQ:BIGC) shares dropped 25.6% to $8.44 after the company reported downbeat Q4 sales and issued weak sales forecast.
- ContextLogic Inc (NASDAQ:WISH) fell 22.4% to $0.56 after the company reported worse-than-expected fourth-quarter sales results.
- Taboola.com Ltd (NASDAQ:TBLA) declined 22.3% to $3.17 after the company reported Q4 financial results.
- Brightcove Inc (NASDAQ:BCOV) dropped 20.7% to $4.98 following weak quarterly results.
- C4 Therapeutics Inc (NASDAQ:CCCC) fell 20.6% to $4.78.
- Ambrx Biopharma Inc - ADR (NYSE:AMAM) fell 18.5% to $5.32 after jumping 45% on Thursday. Ambrx Biopharma recently announced initial data from its ongoing Phase 1 APEX-01 trial of ARX517, Ambrx's proprietary anti-PSMA ADC, in prostate cancer patients.
- NV5 Global Inc (NASDAQ:NVEE) dropped 17.3% to $101.70 following weak quarterly results.
- Pharvaris NV (NASDAQ:PHVS) dropped 14.7% to $7.05.
- Morningstar Inc (NASDAQ:MORN) fell 13.9% to $203.06 after the company reported a year-over-year decrease in Q4 EPS results.
- Opendoor Technologies Inc (NASDAQ:OPEN) shares fell 13.2% to $1.58 after reporting Q4 results.
- E W Scripps Co (NASDAQ:SSP) dropped 12.3% to $12.75 following Q4 results.
- Vascular Biogenics Ltd (NASDAQ:VBLT) fell 11.4% to $0.15. Vascular Biogenics shares jumped around 30% on Thursday after the company and Notable Labs announced a definitive merger agreement.
- World Fuel Services Corp (NYSE:INT) dropped 10.4% to $27.21 after posting downbeat quarterly sales.
- Live Nation Entertainment Inc (NYSE:LYV) fell 10.3% to $68.61 after the company reported mixed Q4 financial results.
- HF Sinclair Corp (NYSE:DINO) fell 9.2% to $48.45 following quarterly results.
- Unisys Corporation (NYSE:UIS) dropped 8% to $5.25 following Q4 results.
Now Read This: Insiders Buying Superior Drilling Products And 2 Other Penny Stocks
